Total Knee Arthroplasty: what cryocompression truly changes in post-operative recovery

Professional Resource5 min read
Total Knee Arthroplasty: what cryocompression truly changes in post-operative recovery
An orthopaedic surgeon operating in theatre, illustrating total knee arthroplasty surgery.
Knee · Professional Resources

Total Knee Arthroplasty: what cryocompression truly changes in post-operative recovery

Professional Resources · Kolde · Reading time: 8 min

A procedure on the rise, and a post-operative phase still left to chance

Total knee arthroplasty (TKA) is now one of the most commonly performed orthopaedic procedures worldwide. In the MENA region, the standardised prevalence of osteoarthritis, the primary indication for TKA, increased by +9.3% between 1990 and 2019, with the knee joint being the most frequently affected.1 Across Gulf Cooperation Council (GCC) countries specifically, a meta-analysis of over 24,000 participants identifies age, female sex and obesity as the main risk factors for a rapidly growing joint pathology.2 The TKA market in the region is in structural expansion.

Yet despite excellent medium-term functional outcomes, the immediate post-operative phase remains a zone of clinical discomfort. Acute pain, joint effusion, arthrogenic muscle inhibition, restricted range of motion: phenomena that, if poorly managed, delay rehabilitation and prolong convalescence. The question is no longer whether cryotherapy is useful after TKA, the literature has established that, but which type, applied how, and above all where: home recovery represents the bulk of the post-operative journey, often left without an appropriate device.

+9.3 %
Rise in knee osteoarthritis prevalence in the MENA region between 1990 and 2019

Why TKA generates such an intense inflammatory response

Understanding the value of cryocompression requires revisiting the pathophysiology of surgical trauma. TKA combines several simultaneous tissue injuries: extensive incision, tourniquet application, bilateral bone resection and prosthetic cementing. The resulting vascular and inflammatory response is proportional to this intensity.

In the hours following surgery, three phenomena cascade and reinforce one another:

  • Haemarthrosis, accumulation of blood in the joint cavity, generates painful capsular distension and reflexively inhibits quadriceps contraction, a mechanism known as arthrogenic muscle inhibition (AMI).6
  • Peri-articular oedema, driven by increased capillary permeability and lymphatic stasis, worsens tissue compression and reduces passive mobility.
  • Nociceptive pain, fuelled by the release of prostaglandins and inflammatory mediators, limits the patient's active participation in rehabilitation.

This triad, effusion, oedema and pain, forms a vicious cycle that pharmacological protocols alone cannot break. This is precisely where active cryocompression intervenes.

i
Key clinical insight

The majority of post-TKA recovery takes place at home. This is where the quality of the first degrees of flexion regained, the speed of oedema resorption and the patient's engagement in rehabilitation are truly decided. Prescribing cryocompression means extending care beyond the clinic walls.

Mechanisms of action: three distinct effects, one simultaneous action

The Game Ready® GRPro 2.1 system acts simultaneously on three complementary physiological dimensions, where traditional ice therapy targets only one.

Cryotherapy

Pain control without opioids

Continuous cold at 4°C slows nociceptive fibre conduction and reduces local metabolism, limiting secondary necrosis and the release of pro-inflammatory mediators, without systemic effects.

Compression

Active oedema resorption

Intermittent pneumatic compression (5 to 75 mmHg) stimulates venous return, activates lymphatic circulation and reduces peri-articular fluid accumulation, a result impossible to achieve with a simple ice pack.

Synergy

Improved range of motion

The combination of cold and compression more rapidly lifts the arthrogenic muscle inhibition caused by effusion, enabling earlier quadriceps activation and accelerated ROM recovery from the very first days.

What the research has shown: accelerated functional recovery

In 2024, a randomised controlled trial published in BMC Musculoskeletal Disorders directly compared active cryocompression (cryotherapy with dynamic compression via the Game Ready®) against standard cryotherapy (ice packs with elastic bandaging) over 21 days of post-TKA rehabilitation.5 The study was conducted at the Clinique de la Porte Verte in Versailles, France.

+99 m
Further on the walk test at Day 21
+10°
Of knee flexion at Day 21
−2.7 cm
Of knee circumference

These results speak directly to the clinician: in rehabilitation, every degree of flexion unlocks a function of daily life. Around 90°, the patient can sit down and rise from a chair or climb stairs; beyond 105 to 110°, they can descend stairs, get up from a low seat and get into a car more easily.

Gaining 10° of flexion earlier is therefore not a mere measurement detail: it means crossing these autonomy thresholds several days sooner and sustaining the momentum of rehabilitation rather than enduring it.

Another research finding: documented opioid sparing

On the question of reducing post-operative opioids, the multicentre prospective randomised trial published in the Journal of Bone & Joint Surgery and conducted at the Hospital for Special Surgery in New York remains a key reference.4 It is one of the few studies to have directly measured the impact of active cryocompression on morphine consumption after TKA.

11
International centres
280
Randomised patients
−25 %
Of morphine over 2 weeks
Direct clinical implication

Less morphine means fewer side effects, but also a more alert, more mobile patient who is better able to actively engage in home rehabilitation from the very first days following discharge, less nausea, less post-operative confusion, less urinary retention.

Clinical implications: what it changes in practice

The available data paint a consistent picture. Active cryocompression after TKA does not replace ERAS protocols (Enhanced Recovery After Surgery, combining multimodal analgesia, early mobilisation and peri-operative optimisation) or multimodal analgesia, but it extends and reinforces them in a measurable way, including beyond the clinic stay.

Pain management

The cold-compression combination reduces nociceptive transmission without systemic effects. At home, the patient can manage cryocompression sessions autonomously, before and after physiotherapy sessions, to better control exertion pain and facilitate mobilisation.

Oedema and effusion

The faster resorption observed in the cryocompression group directly conditions the recovery of joint range of motion. A less swollen joint means rehabilitation progresses and the patient regains confidence in their operated knee sooner.

Functional outcomes

Patients who received active cryocompression reach the clinical recovery thresholds significantly faster. Walking distance at Day 21 confirms this advantage, with a direct impact on the resumption of daily activities at home.

Game Ready at home: how the Kolde rental service works

Post-TKA recovery lasts several weeks. The clinic is only the starting point. Kolde offers Game Ready® GRPro 2.1 device rental directly to the patient's home, for a period of 1 to 4 weeks according to the medical prescription.

1

At the clinic, from Day 0

The device can be applied in the recovery room or ward, using the appropriate knee wrap. This first application initiates the protocol and familiarises the patient with the device before returning home. Kolde also provides direct delivery to the facility on request.

2

Home return, rental from 1 to 4 weeks

Kolde delivers and installs the Game Ready® device directly at the patient's home. The patient leaves with an operational device, a dedicated knee wrap and usage instructions.

3

Autonomous use at home

30-minute sessions, 3 to 5 times per day. The device is used before and after physiotherapy sessions: one session before to prepare and relax the joint, one session after to control the inflammatory response to exertion.

4

End of rental and device pickup

At the end of the rental period, Kolde collects the device from the patient's home. Support is available throughout the rental period to answer questions from the patient or clinician.

Conclusion

Active cryocompression after total knee arthroplasty is no longer a marginal option reserved for elite sports centres. The available data, including two randomised trials, one conducted specifically with the Game Ready®, document measurable clinical benefits on pain, effusion, functional recovery and opioid consumption.

In the Gulf region, where osteoarthritis prevalence and TKA volumes are structurally growing, positioning cryocompression as the standard of post-operative home care is both an evidence-based clinical decision and a concrete response to patient expectations for rapid and comfortable recovery.

Prescribing the Game Ready® at home means extending the clinical benefit of surgery to where recovery truly happens, in the patient's daily life, week after week.

Clinical summary

Active cryocompression after total knee arthroplasty reduces opioid consumption, accelerates effusion resorption and improves short-term functional recovery.

These data support integrating the Game Ready® into the post-operative recovery protocol, from the clinic to the home.

Kolde

References

  1. Shamekh A, Alizadeh M, Nejadghaderi SA, Sullman MJM, Kaufman JS, Collins GS, Kolahi AA, Safiri S. The burden of osteoarthritis in the Middle East and North Africa region from 1990 to 2019. Frontiers in Medicine. 2022. PMID 35814760.
  2. Alenazi AM, Alhowimel AS, Alotaibi MA, Alqahtani BA, Alshehri MM, Alanazi AD, Alanazi AA, Alanazi SF, Bindawas SM. Prevalence and incidence of osteoarthritis among people living in the Gulf Cooperation Council countries: a systematic review and meta-analysis. Clinical Rheumatology. 2021. PMID 33715078.
  3. Salahuddin Salih S, Mustafa Alsalihi R, Esam Mahboub N, Yasir Jasim N, Ali Almutawa R. Assessment of public knowledge and awareness of knee osteoarthritis among individuals aged 18 to 65. Cureus. 2024. PMID 38344565.
  4. Su EP, Perna M, Boettner F, Mayman DJ, Gerlinger T, Barsoum W, Randolph J, Lee G. A prospective, multi-centre, randomised trial to evaluate the efficacy of a cryopneumatic device on total knee arthroplasty recovery. Journal of Bone and Joint Surgery (Br). 2012. PMID 23118406.
  5. Quesnot A, Mouchel S, Ben Salah S, Baranes I, Martinez L, Billuart F. Randomized controlled trial of compressive cryotherapy versus standard cryotherapy after total knee arthroplasty. BMC Musculoskeletal Disorders. 2024. PMID 38419032.
  6. Ewell M, Griffin C, Hull J. The use of focal knee joint cryotherapy to improve functional outcomes after total knee arthroplasty: review article. PM&R. 2014. PMID 24534102.

This article is for information only. It does not replace the advice of a surgeon, doctor or physiotherapist, and it does not constitute a treatment protocol. Indications, contraindications and session parameters remain the responsibility of the prescribing clinician.